No abstract available
MeSH terms
-
Drug Approval
-
Drug Interactions
-
Drug Therapy, Combination
-
Humans
-
Lactones / administration & dosage*
-
Lactones / adverse effects
-
Lactones / pharmacology
-
Myocardial Infarction / drug therapy
-
Peripheral Arterial Disease / drug therapy
-
Pyridines / administration & dosage*
-
Pyridines / adverse effects
-
Pyridines / pharmacology
-
Receptor, PAR-1 / antagonists & inhibitors
-
Thrombosis / prevention & control*
-
United States
-
United States Food and Drug Administration
Substances
-
Lactones
-
Pyridines
-
Receptor, PAR-1
-
vorapaxar